These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis. Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121 [TBL] [Abstract][Full Text] [Related]
26. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3). Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW; EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926 [TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes. Baruch A; van Bruggen N; Kim JB; Lehrer-Graiwer JE Curr Atheroscler Rep; 2013 Jun; 15(6):327. PubMed ID: 23636864 [TBL] [Abstract][Full Text] [Related]
28. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F; Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422 [TBL] [Abstract][Full Text] [Related]
29. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Matusik P; Guzik B; Weber C; Guzik TJ Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109 [TBL] [Abstract][Full Text] [Related]
30. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview. Nidorf SM; Thompson PL Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286 [TBL] [Abstract][Full Text] [Related]
31. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845 [TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanisms of coronary atherosclerotic plaque formation and rupture]. Kume N Nihon Rinsho; 2010 Apr; 68(4):637-41. PubMed ID: 20387554 [TBL] [Abstract][Full Text] [Related]
33. Utility of Lp-PLA2 in lipid-lowering therapy. Racherla S; Arora R Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673 [TBL] [Abstract][Full Text] [Related]
34. [Imaging of atherosclerosis]. Casella G; Prati F; Klauss V; Coutsoumbas G; Di Pasquale G G Ital Cardiol (Rome); 2009 Dec; 10(11-12 Suppl 3):4S-12S. PubMed ID: 21298855 [TBL] [Abstract][Full Text] [Related]
35. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Centurión OA Cardiovasc Revasc Med; 2016 Mar; 17(2):119-28. PubMed ID: 26905055 [TBL] [Abstract][Full Text] [Related]
36. [Lipids and acute coronary syndromes]. Stejfa M Vnitr Lek; 2000 Sep; 46(9):520-5. PubMed ID: 11344644 [TBL] [Abstract][Full Text] [Related]
37. TRPV1: a useful therapeutic target for patients with vulnerable coronary plaques. Li YB; Huang CX Med Hypotheses; 2011 Sep; 77(3):453-5. PubMed ID: 21733634 [TBL] [Abstract][Full Text] [Related]
38. [Anti-platelet therapy in patients with acute coronary syndromes]. Kopaleishvili LA; Dzhashi IM Georgian Med News; 2014 Nov; (236):105-10. PubMed ID: 25541837 [TBL] [Abstract][Full Text] [Related]
39. Statin therapy and the management of acute coronary syndromes. Langer A; Constance C; Fodor JG; Frohlich JJ; Grégoire J; Lau DC; Leiter LA; Mancini GB; Marr D; McPherson R; O'Neill BJ; Rabkin SW Can J Cardiol; 2003 Jul; 19(8):921-7. PubMed ID: 12876613 [TBL] [Abstract][Full Text] [Related]
40. Role of apoptosis in atherosclerosis and its therapeutic implications. Stoneman VE; Bennett MR Clin Sci (Lond); 2004 Oct; 107(4):343-54. PubMed ID: 15230690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]